Acetyl-l-carnitine increases nerve regeneration and target organ reinnervation - a morphological study

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 63, Issue 7, 2010, Pages 1186-1195

  Wilson, Andrew D H ^a,b,c,d   Hart, Andrew ^a,b,c,e   Wiberg, Mikael ^a,b,c   Terenghi, Giorgio ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^e GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Acetyl l carnitine; ALCAR; Nerve injury; Nerve regeneration; Reinnervation; Target organ

Indexed keywords

GENE PRODUCT; LEVACECARNINE; MYELIN; PROTEIN GENE PRODUCT 9.5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; MUSCLE MASS; MYELIN THICKNESS; MYELINATED NERVE; NERVE FIBER; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; REINNERVATION; SCIATIC NERVE; SPRAGUE DAWLEY RAT; STAINING; TARGET ORGAN; THICKNESS; WEIGHT REDUCTION;

ACETYLCARNITINE; ANIMALS; AXONS; HINDLIMB; MUSCLE, SKELETAL; NERVE FIBERS, MYELINATED; NERVE REGENERATION; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SKIN; VITAMIN B COMPLEX;

EID: 77953288217     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2009.05.039     Document Type: Article

References (57)

1. Colucci W.J., and Gandour R.D. Carnitine acyltransferase: a review of its biology, enzymology and bioorganic chemistry. Bioorg Chem 16 (1988) 307-334
2. Tesco G., Latorraca S., Piersanti P., et al. Protection from oxygen radical damage in human diploid fibroblasts by acetyl-l-carnitine. Dementia 3 (1992) 58-60
3. Angelucci L., Ramacci M.T., Taglialatela G., et al. Nerve growth factor binding in aged rat central nervous system: effect of acetyl-l-carnitine. J Neurosci Res 20 (1988) 491-496
4. Taglialatela G., Angelucci L., Ramacci M.T., et al. Stimulation of nerve growth factor receptors in PC12 by acetyl-l-carnitine. Biochem Pharmacol 44 (1992) 577-585
5. Manfridi A., Forloni G.L., Arrigoni-Martelli E., et al. Culture of dorsal root ganglion neurons from aged rats: effects of acetyl-l-carnitine and NGF. Int J Dev Neurosci 10 (1992) 321-329
6. Zhu X., Sato E.F., Wang Y., et al. Acetyl-l-carnitine suppresses apoptosis of thioredoxin 2-deficient DT40 cells. Arch Biochem Biophys 478 (2008) 154-160
7. Di Cesare M.L., Ghelardini C., Calvani M., et al. Neuroprotective effects of acetyl-l-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor. J Neurosci Res (2008)
8. Di Cesare M.L., Ghelardini C., Calvani M., et al. Protective effect of acetyl-l-carnitine on the apoptotic pathway of peripheral neuropathy. Eur J Neurosci 26 (2007) 820-827
9. Wilson A.D.H., Hart A., Brannstrom T., et al. Primary sensory neuronal rescue with systemic acetyl-l-carnitine following peripheral axotomy. A dose-response analysis. Br J Plast Surg 56 (2003) 732-739
10. Hart A.M., Wiberg M., Youle M., et al. Systemic acetyl-l-carnitine eliminates sensory neuronal loss after peripheral axotomy: a new clinical approach in the management of peripheral nerve trauma. Exp Brain Res 145 (2002) 182-189
11. Wilson A.D., Hart A., Brannstrom T., et al. Delayed acetyl-l-carnitine administration and its effect on sensory neuronal rescue after peripheral nerve injury. J Plast Reconstr Aesthet Surg 60 (2007) 114-118
12. McKay Hart A., Wiberg M., and Terenghi G. Pharmacological enhancement of peripheral nerve regeneration in the rat by systemic acetyl-l-carnitine treatment. Neurosci Lett 334 (2002) 181-185
13. Taglialatela G., Angelucci L., Ramacci M.T., et al. Acetyl-l-carnitine enhances the response of PC12 cells to nerve growth factor. Brain Res Dev Brain Res 59 (1991) 221-230
14. McKay H.A., Brannstrom T., Wiberg M., et al. Primary sensory neurons and satellite cells after peripheral axotomy in the adult rat: timecourse of cell death and elimination. Exp Brain Res 142 (2002) 308-318
15. Birch R., Bonney G., and Wynn Parry C.B. Surgical Disorders of the Peripheral Nerves. 1st ed. (1998), Churchill Livingstone
16. Dyck P.G., and O'Brien P.C. Diagnosis, staging and classification of diabetic neuropathy and association with other complications. In: Dyck P.J., Thomas P.K., and Asbury A.K. (Eds). Diabetic Neuropathy (1987), W.B. Saunders, Philadelphia
17. Moyle G.J., and Sadler M. Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management. Drug Saf 19 (1998) 481-494
18. Adle-Biassette H., Bell J.E., Creange A., et al. DNA breaks detected by in situ end-labelling in dorsal root ganglia of patients with AIDS. Neuropathol Appl Neurobiol 24 (1998) 373-380
19. Russell J.W., Sullivan K.A., Windebank A.J., et al. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6 (1999) 347-363
20. Bontioti E., Kanje M., Lundborg G., et al. End-to-side nerve repair in the upper extremity of rat. J Peripher Nerv Syst 10 (2005) 58-68
21. De G.D. Acetyl-l-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review. CNS Drugs 21 Suppl. 1 (2007) 39-43 [discussion 45-6]
22. Sima A.A., Calvani M., Mehra M., et al. Acetyl-l-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care 28 (2005) 89-94
23. Hart A.M., Wilson A.D.H., Montovani C., et al. Acetyl-l-Carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy. AIDS 18 (2004) 1549-1560
24. Herzmann C., Whiting S.J., Thomas M., et al. Pharmacokinetics of acetyl-l-carnitine given in single or multiple doses to HIV-1 infected patients with toxic peripheral polyneuropathy. Open AIDS J 2 (2008) 39-42 Epub@2008 Jun 4
25. Funakoshi H., Risling M., Carlstedt T., et al. Targeted expression of a multifunctional chimeric neurotrophin in the lesioned sciatic nerve accelerates regeneration of sensory and motor axons. Proc Natl Acad Sci U S A 95 (1998) 5269-5274
26. Lago N., Ceballos D., Rodriguez F.J., et al. Long term assessment of axonal regeneration through polyimide regenerative electrodes to interface the peripheral nerve. Biomaterials 26 (2005) 2021-2031
27. Utley D.S., Lewin S.L., Cheng E.T., et al. Brain-derived neurotrophic factor and collagen tubulization enhance functional recovery after peripheral nerve transection and repair. Arch Otolaryngol Head Neck Surg 122 (1996) 407-413
28. Lewin S.L., Utley D.S., Cheng E.T., et al. Simultaneous treatment with BDNF and CNTF after peripheral nerve transection and repair enhances rate of functional recovery compared with BDNF treatment alone. Laryngoscope 107 (1997) 992-999
29. Hazari A., Johansson-Ruden G., Junemo-Bostrom K., et al. A new resorbable wrap-around implant as an alternative nerve repair technique. J Hand Surg [Br] 2 (1999) 291-295
30. Sterne G.D., Brown R.A., Green C.J., et al. Neurotrophin-3 delivered locally via fibronectin mats enhances peripheral nerve regeneration. Eur J Neurosci 9 (1997) 1388-1396
31. Walbeehm E.T., Dudok van Heel E.B., Kuypers P.D., et al. Nerve compound action current (NCAC) measurements and morphometric analysis in the proximal segment after nerve transection and repair in a rabbit model. J Peripher Nerv Syst 8 (2003) 108-115
32. Fernandez E., Pallini R., Gangitano C., et al. Effects of l-carnitine, l-acetylcarnitine and gangliosides on the regeneration of the transected sciatic nerve in rats. Neurol Res 11 (1989) 57-62
33. Thompson R.J., Doran J.F., Jackson P., et al. 9.5 - a new marker for vertebrate neurons and neuroendocrine cells. Brain Res 278 (1983) 224-228
34. Doran J.F., Jackson P., Kynoch P.A., et al. Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J Neurochem 40 (1983) 1542-1547
35. Koskinen M., Hietaharju A., Kylaniemi M., et al. A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy. J Neurol 252 (2005) 789-794
36. Navarro X., Verdu E., Wendelschafer-Crabb G., et al. Immunohistochemical study of skin reinnervation by regenerative axons. J Comp Neurol 380 (1997) 164-174
37. Lindenlaub T., and Sommer C. Epidermal innervation density after partial sciatic nerve lesion and pain-related behavior in the rat. Acta Neuropathol (Berl) 104 (2002) 137-143
38. Lindenlaub T., Teuteberg P., Hartung T., et al. Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res 866 (2000) 15-22
39. Wiberg M., Hazari A., Ljungberg C., et al. Sensory recovery after hand replantation: a clinical, morphological and neurophysical study in humans. Scand J Plast Reconstr Surg Hand Surg 37 (2003) 163-173
40. McCarthy B.G., Hsieh S.T., Stocks A., et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 45 (1995) 1848-1855
41. Verdú E., and Navarro X. Comparison of immunohistochemical and functional reinnervation of skin and muscle after peripheral nerve injury. Exp Neurol 146 (1997) 187-198
42. Pettorossi V.E., Brunetti O., Carobi C., et al. l-Acetylcarnitine enhances functional muscle re-innervation. Drugs Exp Clin Res 17 (1991) 119-125
43. Menderes A., Yilmaz M., Vayvada H., et al. Effects of nerve growth factor on the neurotization of denervated muscles. Ann Plast Surg 48 (2002) 415-422
44. Fitton A.R., Berry M.S., and McGregor A.D. Preservation of denervated muscle form and function by clenbuterol in a rat model of peripheral nerve injury. J Hand Surg [Br] 26 (2001) 335-346
45. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J Anat 194 (1999) 1-14
46. Sima A.A. Acetyl-l-carnitine in diabetic polyneuropathy: experimental and clinical data. CNS Drugs 21 Suppl. 1 (2007) 13-23 [discussion 45-6]
47. Giammusso B., Morgia G., Spampinato A., et al. Improved pallesthetic sensitivity of pedendal nerve in impotent diabetic patients treated with acetyl-l-carnitine. Acta Urol Ital 10 (1996) 185-187
48. De Simone R., Aloe L., Ferraris L., et al. Levocarnitine acetyl treatment promotes iris reinnervation following 6-hydroxydopamine-induced noradrenergic denervation in rats. Int J Clin Pharmacol Res 12 (1992) 281-287
49. Pettorossi V.E., Draicchio F., Fernandez E., et al. The influence of L-acetylcarnitine on reinnervation of the oculomotor nerve. Int J Clin Pharmacol Res 13 (1993) 193-199
50. Fernandez E., Pallini R., Tamburrini G., et al. Effects of levo-acetylcarnitine on second motoneuron survival after axotomy. Neurol Res 17 (1995) 373-376
51. Fernandez E., Pallini R., Gangitano C., et al. Studies on the degenerative and regenerative phenomena occurring after transection and repair of the sciatic nerve in rats: effects of acetyl-l-carnitine. Int J Clin Pharmacol Res 10 (1990) 85-99
52. Day C.S., Riano F., Tomaino M.M., et al. Growth factor may decrease muscle atrophy secondary to denervation. J Reconstr Microsurg 17 (2001) 51-57
53. Day C.S., Buranapanitkit B., Riano F.A., et al. Insulin growth factor-1 decreases muscle atrophy following denervation. Microsurgery 22 (2002) 144-151
54. Bigini P., Larini S., Pasquali C., et al. Acetyl-l-carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons. Neurosci Lett 329 (2002) 334-338
55. Cotter M.A., Cameron N.E., Keegan A., et al. Effects of acetyl- and proprionyl-l-carnitine on peripheral nerve function and vascular supply in experimental diabetes. Metabolism 44 (1995) 1209-1214
56. Spagnoli L.G., Palmieri G., Mauriello A., et al. Morphometric evidence of the trophic effect of l-carnitine on human skeletal muscle. Nephron 55 (1990) 16-23
57. He C., Chen Z., and Chen Z. Enhancement of motor nerve regeneration by nerve growth factor. Microsurgery 13 (1992) 151-154